Filtered By:
Specialty: Internal Medicine
This page shows you your search results in order of date. This is page number 19.
Order by Relevance | Date
Total 3777 results found since Jan 2013.
Prognostic implications of the 4S-AF scheme to characterize new-onset atrial fibrillation after myocardial infarction
CONCLUSIONS: Characterization of NOAF using the 4S-AF scheme aids in the risk stratification of AMI patients with NOAF.PMID:37037721 | DOI:10.1016/j.ejim.2023.04.003
Source: European Journal of Internal Medicine - April 10, 2023 Category: Internal Medicine Authors: Jiachen Luo Zhiqiang Li Xiaoming Qin Xingxu Zhang Xiangdong Liu Wenming Zhang Wei Xu Yiwei Zhang Yuan Fang Baoxin Liu Yidong Wei NOAFCAMI-SH Registry Investigators Source Type: research
Effect of extended duration of thromboprophylaxis for medically ill patients
CONCLUSIONS: Extended thromboprophylaxis, especially with LMWH, showed better efficacy in venous thromboembolism reduction with increased risk of major bleeding. The beneficial effect of LMWH with extended timing has also been shown in stroke patients. Overall, extended thromboprophylaxis is associated with a positive net clinical benefit.PMID:37029050 | DOI:10.1016/j.ejim.2023.03.032
Source: European Journal of Internal Medicine - April 7, 2023 Category: Internal Medicine Authors: Xing Wang Yuqi Chen Dingke Wen Chao You Lu Ma Source Type: research
Oral Anticoagulation in Patients With Advanced Chronic Kidney Disease and Atrial Fibrillation: Beyond Anticoagulation
The optimal approach to prevent stroke and systemic embolism in patients with advanced chronic kidney disease (CKD) and atrial fibrillation remains unresolved. We conducted a narrative review to explore areas of uncertainty and opportunities for future research. First, the relationship between atrial fibrillation and stroke is more complex in patients with advanced CKD than in the general population. The currently employed risk stratification tools do not adequately discriminate between patients deriving a net benefit and those suffering a net harm from oral anticoagulation.
Source: Mayo Clinic Proceedings - April 5, 2023 Category: Internal Medicine Authors: Sofie A.M. Dhaese, An S. De Vriese Tags: Review Source Type: research
The SARS-CoV-2 responsible for phlegmasia cerulea dolens: a case report
CONCLUSION: Although the severe acute respiratory syndrome coronavirus 2 remains a thrombogenic pathology, systematic anticoagulation is the subject of hypothesis. Hence the importance of regular monitoring of markers of vascular thrombosis.PMID:37008170 | PMC:PMC10060091 | DOI:10.1097/MS9.0000000000000152
Source: Annals of Medicine - April 3, 2023 Category: Internal Medicine Authors: Youssef Banana Husam Bashir Sara Boukabous Intissar Haddiya Yassamine Bentata Abdellah Rezziki Adnane Benzirar Omar El Mahi Source Type: research
Association of non-HDL-C-to-HDL-C ratio with coronary lesions and its prognostic performance in first-onset NSTEMI
Conclusion: NON-HDL-C:HDL-C is associated with coronary lesions and prognosis in non-ST-segment elevation acute myocardial infarction.PMID:36994674 | DOI:10.2217/bmm-2022-0548
Source: Future Medicine: Biomarkers in Medicine - March 30, 2023 Category: Internal Medicine Authors: Qi Mao Jianhua Zhao Xiaohui Zhao Source Type: research
The initial timing and dosage pattern of sacubitril/valsartan in patients with acute myocardial infarction undergoing percutaneous coronary intervention
CONCLUSIONS: Early use or high dosage of sacubitril/valsartan medication is associated with an improvement in clinical outcome. The low dose of sacubitril/valsartan is well tolerated and may be an acceptable alternative strategy.PMID:36990878 | DOI:10.1016/j.ejim.2023.03.019
Source: European Journal of Internal Medicine - March 29, 2023 Category: Internal Medicine Authors: Jun Gu Yue Wang Chang-Qian Wang Jun-Feng Zhang Source Type: research
The association between direct oral anticoagulant concentration upon acute stroke and stroke outcome
CONCLUSION: Among DOAC users who developed IS, low drug concentrations at hospital presentation predicted poor outcomes.PMID:36990874 | DOI:10.1016/j.ejim.2023.03.023
Source: European Journal of Internal Medicine - March 29, 2023 Category: Internal Medicine Authors: Shin-Yi Lin Sung-Chun Tang Ching-Hua Kuo Chih-Hao Chen Yuan-Chang Chao Chih-Fen Huang Jiann-Shing Jeng Source Type: research
The initial timing and dosage pattern of sacubitril/valsartan in patients with acute myocardial infarction undergoing percutaneous coronary intervention
CONCLUSIONS: Early use or high dosage of sacubitril/valsartan medication is associated with an improvement in clinical outcome. The low dose of sacubitril/valsartan is well tolerated and may be an acceptable alternative strategy.PMID:36990878 | DOI:10.1016/j.ejim.2023.03.019
Source: European Journal of Internal Medicine - March 29, 2023 Category: Internal Medicine Authors: Jun Gu Yue Wang Chang-Qian Wang Jun-Feng Zhang Source Type: research
The association between direct oral anticoagulant concentration upon acute stroke and stroke outcome
CONCLUSION: Among DOAC users who developed IS, low drug concentrations at hospital presentation predicted poor outcomes.PMID:36990874 | DOI:10.1016/j.ejim.2023.03.023
Source: European Journal of Internal Medicine - March 29, 2023 Category: Internal Medicine Authors: Shin-Yi Lin Sung-Chun Tang Ching-Hua Kuo Chih-Hao Chen Yuan-Chang Chao Chih-Fen Huang Jiann-Shing Jeng Source Type: research
